25-11-2021 23:10 via boerse-online.de

EQS-Adhoc: IGEA Pharma N.V.: GBC AG PUBLISHES INITIAL EQUITY RESEARCH REPORT WITH BUY RECOMMENDATION AND PRICE TARGET OF EUR 1.05

<table border="0"><tr><td>
EQS Group-Ad-hoc: <a href="/aktien/igea_pharma-aktie">IGEA Pharma</a> N.V. / Key word(s): Research Update/Research Update<br/>IGEA Pharma N.V.: GBC AG PUBLISHES INITIAL EQUITY RESEARCH REPORT WITH BUY RECOMMENDATION AND PRICE TARGET OF EUR 1.05 <br/><br/>
25-Nov-2021 / 23:10 CET/CEST<br/>Release of an ad hoc...
Weiterlesen »